Impact of disseminating quality improvement programs for depression in managed primary care: A randomized controlled trial

JAMA

Volumn 283, Issue 2, 2000, Pages 212-220

  Wells, Kenneth B ^a,b,c   Sherbourne, Cathy ^b   Schoenbaum, Michael ^b   Duan, Naihua ^b   Meredith, Lisa ^b   Unützer, Jürgen ^c   Miranda, Jeanne ^e   Carney, Maureen F ^b   Rubenstein, Lisa V ^b,d,f  

^a Health Program ^*  (United States)

^b RAND CORPORATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^f VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; COUNSELING; DATA ANALYSIS; DEPRESSION; EMPLOYMENT; FEMALE; HUMAN; MALE; MANAGED CARE; MENTAL HEALTH SERVICE; PATIENT CARE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS;

EID: 0034639475     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.2.212     Document Type: Article

References (45)

1. Wells KB, Sturm R, Sherbourne CD, Meredith LS. Caring for Depression. Cambridge, Mass: Harvard University Press; 1996.
2. Wells KB, Schoenbaum M, Unützer J, Lagomasino IT, Rubenstein LV. Quality of care for depressed primary care patients. Arch Fam Med. 1999;8:529-536.
3. Sturm R, Wells KB. How can care for depression become more cost-effective? JAMA. 1995;273:51-58.
4. Murray CJ, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Disease, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston, Mass: The Harvard School of Public Health on behalf of the World Health Organization and The World Bank; 1996.
5. Depression Guidelines Panel. Depression in Primary Care, I: Detection and Diagnosis. Rockville, Md: US Dept of Health and Human Services; 1993. US Public Health Service, Agency for Health Care Policy and Research publication 93-0550.
6. Depression Guidelines Panel. Depression in Primary Care, II: Treatment of Major Depression. Rockville, Md: US Dept of Health and Human Services; 1993. US Public Health Service, Agency for Health Care Policy and Research publication 93-0551.
7. Schulberg HC, Block MR, Madonia MJ, et al. Treating major depression in primary care practice: 8-month clinical outcomes. Arch Gen Psychiatry. 1996;53:913-919.
8. Malt UF, Robak OH, Madsbu H-P, Bakke O, Loeb M. The Norwegian Naturalistic Treatment Study of Depression in General Practice (NORDEP)-I: randomized double blind study. BMJ. 1999;318:1180-1184.
9. Attikson CC, Zich JM. Depression in Primary Care: Screening and Detection. New York, NY: Routledge; 1990.
10. Brown JB, Shye D, McFarland B. The paradox of guideline implementation: how AHCPR's depression guideline was adapted at Kaiser Permanente Northwest Region. J Qual Improvement. 1995;21:5-21.
11. Katon W, VonKorff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273: 1026-1031.
12. Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996; 53:924-932.
13. Lin E, Katon W, Simon G, et al. Achieving guidelines for the treatment of depression in primary care: is physician education enough? Med Care. 1998;35; 831-842.
14. Mittman BS, Tonesk X, Jacobson P. Implementing clinical practice guidelines, social influence strategies, and practitioner behavior change. Qual Rev Bull. 1992;18:413-422.
15. Rubenstein LV, McCoy JM, Cope DW, et al. Improving patient quality of life with feedback to physicians about functional status. J Gen Intern Med. 1995; 10:607-614.
16. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996:74:511-544.
17. Antonuccio DO, Danton WG, Denelsky GY. Psychotherapy versus medication for depression: challenging the conventional wisdom with data. Prof Psychol Res Pract. 1995;26:574-585.
18. Hay Group. Health Care Plan Design and Cost Trends - 1988 Through 1997. Washington, DC: Hay Group; 1998.
19. Rapaport MH, Judd LL. Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment. J Affect Disord. 1998;48:227-232.
20. Szegedi A, Wetzel H, Angersbach D, Philipp M, Benkert O. Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline. J Affect Disord. 1997;45:167-178.
21. Szegedi A, Wetzel H, Angersbach D, et al. A double-blind study comparing paroxetine and maprotiline in depressed outpatients. Pharmacopsychiatry. 1997;30:97-105.
22. Evans MD, Hollon SD, DeRubeis RJ, et al. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry. 1992;49:802-808.
23. Keller MB, Kocsis JH, Thase ME, et al. Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA. 1998;280: 1665-1672
24. Miranda J, Munoz R. Intervention for minor depression in primary care patients. Psychosom Med. 1989;56:136-142.
25. Wells KB. The design of Partners in Care: evaluating the cost-effectiveness of improving care for depression in primary care. Soc Psychiatry Psychiatr Epidemiol. 1999;34:20-29.
26. Murray DM. Design and Analysis of Group-Randomized Trials. New York, NY: Oxford University Press; 1998.
27. World Health Organization. Composite International Diagnostic Interview (CIDI), Version 2.1. Geneva, Switzerland: World Health Organization; 1995.
28. Rubenstein LV, Jackson-Triche M, Unützer J, et al. Evidence-based care for depression in managed primary care practices. Health Aff (Millwood). 1999;18: 89-105.
29. Rubenstein LV, Unützer J, Miranda J, et al. Partners in Care Guidelines and Resources for Depression Nurse Specialist. Santa Monica, Calif: Partners in Care, RAND; 1996.
30. Rubenstein LV, Unützer J, Miranda J, et al. Clinician Guide to Depression and Management in Primary Care Settings. Santa Monica, Calif: Partners in Care, RAND; 1996.
31. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York, NY: The Guilford Press; 1979.
32. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement. 1977;1:385-401.
33. Hambleton R, Swaminathan H. Item Response Theory: Principles and Applications. Boston, Mass: Kluwer-Nijhoff; 1985.
34. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30:473-483.
35. Ware JE Jr, Kosinski M, Keller SD. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales. Boston, Mass: The Health Institute, New England Medical Center; 1995.
36. Wells KB, Katon W, Rogers B, Camp P. Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the Medical Outcomes Study. Am J Psychiatry. 1994;151:694-700.
37. Katon W, VonKorff M, Lin E, Bush T, Ormel J. Adequacy of duration of antidepressant treatment in primary care. Med Care. 1992;30:67-76.
38. Smith JP. Racial and ethnic differences in wealth in the Health and Retirement Study. J Hum Resources. 1995;30(suppl):S158-S183.
39. Schafer JL. Analysis of Incomplete Multivariate Data. London, England: Chapman & Hall; 1997.
40. Rubin DB. Multiple imputation after 18 years. J Am Stat Assoc. 1996:91:473-489.
41. Rubin DB Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley & Sons; 1987.
42. Miller RG Jr. Simultaneous Statistical Inference. 2nd ed. New York, NY: Springer-Verlag; 1980.
43. Kessler RC, McGonagle KA, Ahao S, et al. Lifetime and 12-month prevalence of DSM-II-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
44. Mintz J, Mintz LI, Arruda MJ, Hawng SS. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry. 1992;49:761-768.
45. Wells KB. Treatment research at the crossroads: the scientific interface of clinical trials and health services research. Am J Psychiatry. 1999;156:5-10.